Multiple common fragile sites are expressed in the genome of the laboratory rat.
Splenic lymphocytes from Sprague Dawley and Fischer 344 rats were exposed to two chemicals known to induce common fragile site expression in man: fluorodeoxyuridine (in conjunction with the enhancing effects of caffeine) and aphidicolin. Of 39 sites that were significantly damaged in excess, 12 meet the criteria for fragility proposed in this investigation. Rat fragile sites appear to differ from those in man in that no common hierarchical frequency of expression is evident from the two methods of induction. In addition, a comparison of published cancer-specific chromosome breakpoints from a variety of rat tumors reveals little or no apparent concordance with the identified fragile sites. The rat is an animal model in which multiple common fragile sites can be induced and, as such, will be valuable for testing hypotheses concerning the biological basis of chromosomal fragility.
D000818:Animals; D016590:Aphidicolin; D002110:Caffeine / Q000494:pharmacology; D043283:Chromosome Fragile Sites; D002873:Chromosome Fragility; D004224:Diterpenes / Q000494:pharmacology; D005260:Female; D005467:Floxuridine / Q000494:pharmacology; D006720:Homozygote; D066298:In Vitro Techniques; D008297:Male; D051381:Rats / Q000235:genetics*; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains
D004224:Diterpenes; D005467:Floxuridine; D016590:Aphidicolin; D002110:Caffeine